Consistent with our previous findings of a stronger and more durable mucosal spike IgA response to reinfection as compared to primary infection,22,26 we now demonstrate progressively higher mucosal spike IgA levels with each subsequent SARS-CoV-2 infection. The gene discussed is CD79A; the disease is infection.